Through HealthXL, Roche Diagnostics is to collaborate with innovative Connected Health companies globally
Last week, HealthXL -- a global market for health innovation -- announced that Roche Diagnostics joins the HealthXL network to collaborate with industry leaders and innovative connected health companies globally.
Roche Diagnostics joins a network of 16 HealthXL partners including leading global healthcare brands such as Bupa, Cleveland Clinic, Becton Dickinson, IBM, ICON, ResMed, Janssen Healthcare Innovation, Linde Healthcare, Novartis, Partners HealthCare, Silicon Valley Bank, EY, SoftServe, Hermitage Medical Clinic, SoftLayer, Apollo Hospitals.
“Through HealthXL, we will further expand our activities in the Connected Health and Chronic Disease Management domain globally by exploring the opportunities to collaborate with other HealthXL partners, as well as with innovative connected health companies” said Jochen Hurlebaus, Head of Central R&D Services - Innovation & IP Management at Roche Diagnostics.
“Roche Diagnostics is the global leader for diagnostics and we are delighted to have them on board”, said Martin Kelly, CEO and Founder of HealthXL. “Bringing a clinical diagnostics partner will help the partners in our network to bridge benchside diagnostics to the wider ecosystem of connected care.”
The announcement came during Martin Kelly’s talk on “Trends in Digital Health Investments & Ecosystems” at TechTour’s Healthtech Summit recently in Lausanne, Switzerland. See Martin’s deck on Slideshare.
HealthXL and its clients are constantly exploring similar opportunities in healthcare to work with high growth companies, increasing the speed at which existing digital health technologies can begin to have a meaningful impact on health outcomes.
Posts from the community are NOT edited, checked for accuracy of facts, censored, nor endorsed by nuviun. All opinions are solely those of the authors.